Trilostane information

Trilostane
Clinical data
Trade names	Vetoryl, others
Other names	WIN-24,540; 4α,5-Epoxy-3,17β-dihydroxy-5α-androst-2-ene-2-carbonitrile
Routes of; administration	By mouth
ATC code	H02CA01 (WHO) QH02CA01 (WHO);
Legal status
Legal status	CA: ℞-only; US: ℞-only;
Pharmacokinetic data
Metabolism	Liver
Metabolites	17-Ketotrilostane
Elimination half-life	Trilostane: 1.2 hours; 17-Ketotrilostane: 1.2 hours
Identifiers
	IUPAC name (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile;
CAS Number	13647-35-3 ;
PubChem CID	656583;
IUPHAR/BPS	6850;
DrugBank	DB01108 ;
ChemSpider	570949 ;
UNII	L0FPV48Q5R;
KEGG	D01180 ;
ChEBI	CHEBI:32260 ;
ChEMBL	ChEMBL1200907 ;
CompTox Dashboard (EPA)	DTXSID9023706 ;
ECHA InfoCard	100.033.743
Chemical and physical data
Formula	C20H27NO3
Molar mass	329.440 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES N#C\C4=C(/O)[C@H]5O[C@]35[C@]([C@@H]2[C@H]([C@H]1[C@]([C@@H](O)CC1)(C)CC2)CC3)(C)C4;
	InChI InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 ; Key:KVJXBPDAXMEYOA-CXANFOAXSA-N ;
	(verify)

Trilostane, sold under the brand name Vetoryl among others, is a medication which has been used in the treatment of Cushing's syndrome, Conn's syndrome, and postmenopausal breast cancer in humans.^[2]^[3]^[4]^[5]^[1] It was withdrawn for use in humans in the United States in the 1990s^[6] but was subsequently approved for use in veterinary medicine in the 2000s to treat Cushing's syndrome in dogs.^[7] It is taken by mouth.^[1]

^ ^a ^b ^c ^d ^e ^f Puddefoot JR, Barker S, Vinson GP (December 2006). "Trilostane in advanced breast cancer". Expert Opinion on Pharmacotherapy. 7 (17): 2413–2419. doi:10.1517/14656566.7.17.2413. PMID 17109615. S2CID 23940491.
^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1245–. ISBN 978-1-4757-2085-3.
^ Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 281–. ISBN 978-94-011-4439-1.
^ Negwer M (1987). Organic-chemical Drugs and Their Synonyms: (an International Survey). VCH Publishers. ISBN 978-0-89573-552-2. 5870 (6516) C20H2:NOs 13647-35-3 42,5-Epoxy-173-hydroxy-3-oxo-50-androstane-22carbonitrile = (22,42,52,173)-4,5-Epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile (e) S Desopan, Modrastane, Modrenal, Trilostane", Trilox, Win 24 540, Winstan U Adrenocortical suppressant (steroid biosynthesis inhibitor)
^ Milne GW (8 May 2018). Drugs: Synonyms and Properties: Synonyms and Properties. Taylor & Francis. pp. 34–. ISBN 978-1-351-78989-9.
^ Tung D, Ciallella J, Hain H, Cheung PH, Saha S (December 2013). "Possible therapeutic effect of trilostane in rodent models of inflammation and nociception". Current Therapeutic Research, Clinical and Experimental. 75: 71–76. doi:10.1016/j.curtheres.2013.09.004. PMC 3898193. PMID 24465047.
^ "Cushing's Disease in Dogs Part 3: Current & Investigative Options for Therapy". Today's Veterinary Practice. 2016-02-24. Retrieved 2021-01-04.

[pmid17109615-1] ^ ^a ^b ^c ^d ^e ^f Puddefoot JR, Barker S, Vinson GP (December 2006). "Trilostane in advanced breast cancer". Expert Opinion on Pharmacotherapy. 7 (17): 2413–2419. doi:10.1517/14656566.7.17.2413. PMID 17109615. S2CID 23940491.

[Elks2014-2] Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1245–. ISBN 978-1-4757-2085-3.

[MortonHall2012-3] Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 281–. ISBN 978-94-011-4439-1.

[Negwer1987-4] Negwer M (1987). Organic-chemical Drugs and Their Synonyms: (an International Survey). VCH Publishers. ISBN 978-0-89573-552-2. 5870 (6516) C20H2:NOs 13647-35-3 42,5-Epoxy-173-hydroxy-3-oxo-50-androstane-22carbonitrile = (22,42,52,173)-4,5-Epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile (e) S Desopan, Modrastane, Modrenal, Trilostane", Trilox, Win 24 540, Winstan U Adrenocortical suppressant (steroid biosynthesis inhibitor)

[Milne2018-5] Milne GW (8 May 2018). Drugs: Synonyms and Properties: Synonyms and Properties. Taylor & Francis. pp. 34–. ISBN 978-1-351-78989-9.

[pmid24465047-6] Tung D, Ciallella J, Hain H, Cheung PH, Saha S (December 2013). "Possible therapeutic effect of trilostane in rodent models of inflammation and nociception". Current Therapeutic Research, Clinical and Experimental. 75: 71–76. doi:10.1016/j.curtheres.2013.09.004. PMC 3898193. PMID 24465047.

[7] "Cushing's Disease in Dogs Part 3: Current & Investigative Options for Therapy". Today's Veterinary Practice. 2016-02-24. Retrieved 2021-01-04.

Trilostane information

and 27 Related for: Trilostane information

Trilostane

Alopecia X

Nicotinamide

Thalidomide

Testosterone

List of veterinary drugs

Progesterone

Triamcinolone

Metandienone

Estrogen

Prednisone

Clobetasol propionate

Spironolactone

DDT

Dexamethasone

Steroid

Endocrine disruptor

Quercetin

Fluticasone propionate

Aromatase inhibitor

Mometasone

Azelaic acid

Aldosterone

Methylprednisolone aceponate

Hydrocortisone

Estradiol

Topical steroid